Worthley Stephen G, Farouque H M Omar, Cameron James D, Meredith Ian T
Royal Adelaide Hospital, Monash Medical Centre, Adelaide, Australia.
J Invasive Cardiol. 2006 Jan;18(1):28-31.
Positive coronary artery remodeling is associated with unstable coronary syndromes. Serum inflammatory markers, including high-sensitivity CRP (hsCRP), can predict future risk of acute coronary events in patients with stable coronary artery disease. We sought to elucidate the relationship of specific serum inflammatory markers with intravascular ultrasound (IVUS) estimation of coronary artery remodeling in patients with stable coronary artery disease. Thirty-one sequential patients at our institution undergoing IVUS-assisted percutaneous coronary intervention (PCI) with stable coronary artery disease were enrolled. Automated IVUS pullback and offline analysis were performed in all patients. Images were analyzed for vessel wall area (VWA) and lumen area (LA), at the culprit lesion and at a proximal reference site, and the remodeling index (RI) was calculated. Positive and negative remodeling were defined as a RI of > 1.05 and < 0.95, respectively. ELISA essays were performed for soluble VCAM-1, ICAM-1 and E-selectin. The distribution of data followed a lognormal distribution. By defining arterial remodeling as simply positive or negative, significant differences were identified for log E-selectin only (1.80 +/- 0.04 versus 1.62 +/- 0.05, respectively; p = 0.02). The RI correlation coefficient was 0.38 (p = 0.04) for log sVCAM-1 and 0.42 (p = 0.02) for log sICAM-1. The log E-selection and RI correlation coefficient, although weaker at 0.32, showed a trend toward significance (p = 0.08). There was no significant correlation between log hsCRP and RI (p = 0.42). Using step-wise multivariate analysis, log sVCAM-1 only remained an independent predictor of the RI (p = 0.03). Positive coronary artery remodeling correlates with serological markers of inflammation in patients with stable coronary artery disease.
冠状动脉正向重塑与不稳定型冠状动脉综合征相关。血清炎症标志物,包括高敏C反应蛋白(hsCRP),可预测稳定型冠状动脉疾病患者未来发生急性冠状动脉事件的风险。我们试图阐明特定血清炎症标志物与稳定型冠状动脉疾病患者冠状动脉重塑的血管内超声(IVUS)评估之间的关系。我们纳入了本院31例接受IVUS辅助经皮冠状动脉介入治疗(PCI)的稳定型冠状动脉疾病患者。对所有患者进行自动IVUS回撤和离线分析。分析罪犯病变处及近端参考部位的血管壁面积(VWA)和管腔面积(LA),并计算重塑指数(RI)。正向和负向重塑分别定义为RI>1.05和<0.95。采用酶联免疫吸附测定法检测可溶性血管细胞黏附分子-1(sVCAM-1)、细胞间黏附分子-1(ICAM-1)和E-选择素。数据分布呈对数正态分布。通过简单地将动脉重塑定义为正向或负向,仅发现对数E-选择素存在显著差异(分别为1.80±0.04和1.62±0.05;p=0.02)。对数sVCAM-1的RI相关系数为u003d0.38(p=0.04),对数sICAM-1的RI相关系数为0.42(p=0.02)。对数E-选择素与RI的相关系数虽然较弱,为0.32,但呈显著趋势(p=0.08)。对数hsCRP与RI之间无显著相关性(p=0.42)。采用逐步多变量分析,仅对数sVCAM-1仍然是RI的独立预测因子(p=0.03)。冠状动脉正向重塑与稳定型冠状动脉疾病患者的炎症血清学标志物相关。